Next Generation News and Research

RSS

Bioethics in pharmaceutical industry, regenerative medicine, and public health

To celebrate 40 years of pioneering bioethics publication, the Hastings Center Report, the world's first bioethics journal, looked to the future, asking young scholars to write about what the next generation of bioethicists should take up. Out of 195 compelling submissions, four of the best essays were selected for publication in the November-December issue.

12 Nov 2010

Eight students to receive Hartford Doctoral Fellowship in geriatric social work

Eight outstanding students have been chosen as the newest recipients of the prestigious Hartford Doctoral Fellowship in geriatric social work. The program is funded by the John A. Hartford Foundation, administered by The Gerontological Society of America, and directed by James Lubben, DSW, MPH.

12 Nov 2010

Acetylon receives two grants under QTDP program to advance HDAC6 inhibitor drug candidate

Acetylon Pharmaceuticals, Inc. today announced that it has been awarded two grants totaling $488,000 under the Qualifying Therapeutic Discovery Project (QTDP) program.

12 Nov 2010

New Alma’s Soprano laser technology delivers painless procedure for hair removal

Alma Lasers, Ltd., a leader in laser, light, radiofrequency and ultrasound-based aesthetic devices, unveils the latest in next generation medical laser technology with the debut of its new Soprano(XLi) for laser hair removal and deep dermal heating.

12 Nov 2010

Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications

Roche Diagnostics and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray technologies and complementary products for molecular diagnostic applications.

From Roche Sequencing and Life Science 11 Nov 2010

BioWorld Today features ImmunGene's pipeline of next generation armed antibodies for cancer

ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that a profile of the company and its pipeline is featured in the November 21 issue of BioWorld Today in the NewCo section.

11 Nov 2010

New national strategy to end tobacco addiction

Our national strategy to end tobacco addiction has stalled, putting the nation's health and economic well-being at risk, said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group, and author of The Latina Guide to Health.

11 Nov 2010

BIOTRONIK releases Pulsar-18 stent for treatment of long lesions in superficial femoral, infrapopliteal arteries

BIOTRONIK AG, a European manufacturer of therapy solutions for vascular intervention, has announced the international full market release of the innovative Pulsar-18 stent for treatment of long lesions in the superficial femoral and infrapopliteal arteries. Pulsar-18 is unique in the market, representing an advance in technology that further reinforces the company's position as a leader in providing high quality technologies for patients with peripheral vascular disease.

11 Nov 2010

SRU Biosystems announces launch of annual Label-free Technology Award

SRU Biosystems, a leader in label-free technologies, announced today the launch of its annual Label-free Technology Award. This year the company will award its newest label-free BIND SCANNER to an academic or non-profit laboratory to support innovative scientific and drug discovery research.

11 Nov 2010

Accreditation Council for Graduate Medical Education to honor LA BioMed researcher

The Accreditation Council for Graduate Medical Education will honor Christian de Virgilio, MD, a principal investigator at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), with its Parker J. Palmer Courage to Teach Award for Program Director Excellence at its 2011 awards ceremony in Nashville, Tenn.

10 Nov 2010

NCI awards $4 million for UNM's cancer nanotechnology partnership with Sandia Labs

The National Cancer Institute recently announced two five-year awards totaling nearly $4 million for a partnership between the University of New Mexico Cancer Center and Sandia National Laboratories. One $1.95 million grant will fund the creation of a joint Cancer Nanotechnology Platform Partnership, and another $1.8 million grant will pay for a new Cancer Nanotechnology Training Center to train a new generation of multidisciplinary scientists.

10 Nov 2010

Enrollment complete in Nabi's second NicVAX Phase III clinical trial for nicotine addiction

Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.

10 Nov 2010

ARIAD reports $20.4 million net loss for third quarter 2010

ARIAD Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2010 and provided an update on corporate developments.

9 Nov 2010

New COLD-PCR technology to detect EGFR gene mutation

Transgenomic, Inc. today announced completion of a development study of several new assays to detect genetic mutations using the Company's proprietary Co-amplification at Lower Denaturing Temperature PCR (COLD-PCR) technology in the Epidermal Growth Factor Receptor (EGFR) gene.

8 Nov 2010

MitoSciences awarded $244,000 grant under IRS Qualifying Therapeutic Discovery Project

MitoSciences Inc. today announces that it has been awarded a $244,000 grant under the IRS Qualifying Therapeutic Discovery Project. This award was made in support of MitoSciences' efforts to develop the world's most advanced set of assays for unlocking the role of metabolism in cancer and other critical diseases, and for helping researchers to design and monitor the most effective therapies for those conditions.

8 Nov 2010

InNexus receives $116,760 cash grant under QTDP program to develop DXL anti-cancer antibodies

InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.

8 Nov 2010

New benchtop robotic workstation simplifies next-generation sequencing workflows

IntegenX, Inc. today at the 60th Annual American Society of Human Genetics Meeting announced the launch of their Apollo 324 System, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing.

8 Nov 2010

Ortho-McNeil terminates collaboration agreement with Arena on APD597 trial program

Arena Pharmaceuticals, Inc. announced today that, following the completion of a Phase 1 clinical trial program for APD597 (JNJ-38431055) under its collaboration with Arena, Ortho-McNeil-Janssen Pharmaceuticals, Inc., has decided not to advance APD597 and has notified Arena that it is terminating the collaboration, effective December 28, 2010.

7 Nov 2010

Viking Systems third quarter sales decreases 8% to $1,832,502

Viking Systems, Inc. today announced financial results for its third quarter ended September 30, 2010. The Company reported a net loss for the quarter ended September 30, 2010 of $632,565 or $0.01 per share and net loss of $1,378,865 or $0.03 per share for the nine months ended September 30, 2010.

4 Nov 2010

RF Surgical introduces new RF Assure Detection platform

RF Surgical Systems, Inc., the market leader in the prevention and detection of retained surgical sponges, today announced the availability of the RF Assure™ Detection System Model 200.

4 Nov 2010

Next Generation News and Research

Bioethics in pharmaceutical industry, regenerative medicine, and public health

Eight students to receive Hartford Doctoral Fellowship in geriatric social work

Acetylon receives two grants under QTDP program to advance HDAC6 inhibitor drug candidate

New Alma’s Soprano laser technology delivers painless procedure for hair removal

Roche, CapitalBio to initiate strategic partnership for molecular diagnostic applications

BioWorld Today features ImmunGene's pipeline of next generation armed antibodies for cancer

New national strategy to end tobacco addiction

BIOTRONIK releases Pulsar-18 stent for treatment of long lesions in superficial femoral, infrapopliteal arteries

SRU Biosystems announces launch of annual Label-free Technology Award

Accreditation Council for Graduate Medical Education to honor LA BioMed researcher

NCI awards $4 million for UNM's cancer nanotechnology partnership with Sandia Labs

Enrollment complete in Nabi's second NicVAX Phase III clinical trial for nicotine addiction

ARIAD reports $20.4 million net loss for third quarter 2010

New COLD-PCR technology to detect EGFR gene mutation

MitoSciences awarded $244,000 grant under IRS Qualifying Therapeutic Discovery Project

InNexus receives $116,760 cash grant under QTDP program to develop DXL anti-cancer antibodies

New benchtop robotic workstation simplifies next-generation sequencing workflows

Ortho-McNeil terminates collaboration agreement with Arena on APD597 trial program

Viking Systems third quarter sales decreases 8% to $1,832,502

RF Surgical introduces new RF Assure Detection platform

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News